Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Asadi

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Scientific Reports|May 20, 2025
1-Phenyl-β-carboline-3-carboxamide-1,2,3-triazole-N-phenylacetamide hybrids as new α-glucosidase inhibitorsElham Safaie, Mohammad Hosein Sayahi, Navid Dastyafteh, et al.
Scientific Reports|January 3, 2025
Cinnamic acid conjugated with triazole acetamides as anti-Alzheimer and anti-melanogenesis candidates: an in vitro and in silico studyAmir Shervin Shokouhi Asl, Mohammad Hosein Sayahi, Mohammad Hashem Hashempur, et al.
Scientific Reports|June 30, 2025
Author Correction: 1-Phenyl-β-carboline-3-carboxamide-1,2,3-triazole-N-phenylacetamide hybrids as new α-glucosidase inhibitorsElham Safaie, Mohammad Hosein Sayahi, Navid Dastyafteh, et al.
Scientific Reports|August 15, 2022
Design and synthesis of new N-thioacylated ciprofloxacin derivatives as urease inhibitors with potential antibacterial activityKeyvan Pedrood, Homa Azizian, Mohammad Nazari Montazer, et al.
Scientific Reports|June 22, 2023
[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as new therapeutic candidates against urease positive microorganisms: design, synthesis, pharmacological evaluations, and in silico studiesMinoo Khalili Ghomi, Milad Noori, Mohammad Nazari Montazer, et al.
Bioorganic Chemistry|January 20, 2024
Alpha-glucosidase inhibitory and hypoglycemic effects of imidazole-bearing thioquinoline derivatives with different substituents: In silico, in vitro, and in vivo evaluationsAnita Azmi, Milad Noori, Minoo Khalili Ghomi, et al.
Scientific Reports|February 8, 2022
Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agentsMarzieh Sohrabi, Mohammad Nazari Montazer, Sara Moghadam Farid, et al.
RSC Advances|November 6, 2024
Design, synthesis, biological evaluation, and <i>in silico</i> studies of novel <i>N</i>-substituted-2-(3,4,5-trimethoxyphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazole-6-carboxamides as promising anticancer agentsNavid Dastyafteh, Manica Negahdaripour, Mohammad Hosein Sayahi, et al.
European Journal of Medicinal Chemistry|March 20, 2024
Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic propertiesMinoo Khalili Ghomi, Milad Noori, Maryam Mirahmad, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Scientific Reports|May 20, 2025
1-Phenyl-β-carboline-3-carboxamide-1,2,3-triazole-N-phenylacetamide hybrids as new α-glucosidase inhibitorsElham Safaie, Mohammad Hosein Sayahi, Navid Dastyafteh, et al.
Scientific Reports|January 3, 2025
Cinnamic acid conjugated with triazole acetamides as anti-Alzheimer and anti-melanogenesis candidates: an in vitro and in silico studyAmir Shervin Shokouhi Asl, Mohammad Hosein Sayahi, Mohammad Hashem Hashempur, et al.
Scientific Reports|June 30, 2025
Author Correction: 1-Phenyl-β-carboline-3-carboxamide-1,2,3-triazole-N-phenylacetamide hybrids as new α-glucosidase inhibitorsElham Safaie, Mohammad Hosein Sayahi, Navid Dastyafteh, et al.
Scientific Reports|August 15, 2022
Design and synthesis of new N-thioacylated ciprofloxacin derivatives as urease inhibitors with potential antibacterial activityKeyvan Pedrood, Homa Azizian, Mohammad Nazari Montazer, et al.
Scientific Reports|June 22, 2023
[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as new therapeutic candidates against urease positive microorganisms: design, synthesis, pharmacological evaluations, and in silico studiesMinoo Khalili Ghomi, Milad Noori, Mohammad Nazari Montazer, et al.
Bioorganic Chemistry|January 20, 2024
Alpha-glucosidase inhibitory and hypoglycemic effects of imidazole-bearing thioquinoline derivatives with different substituents: In silico, in vitro, and in vivo evaluationsAnita Azmi, Milad Noori, Minoo Khalili Ghomi, et al.
Scientific Reports|February 8, 2022
Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agentsMarzieh Sohrabi, Mohammad Nazari Montazer, Sara Moghadam Farid, et al.
RSC Advances|November 6, 2024
Design, synthesis, biological evaluation, and <i>in silico</i> studies of novel <i>N</i>-substituted-2-(3,4,5-trimethoxyphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazole-6-carboxamides as promising anticancer agentsNavid Dastyafteh, Manica Negahdaripour, Mohammad Hosein Sayahi, et al.
European Journal of Medicinal Chemistry|March 20, 2024
Evaluation of novel 2-(quinoline-2-ylthio)acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo studies on their anti-diabetic propertiesMinoo Khalili Ghomi, Milad Noori, Maryam Mirahmad, et al.
Pageof 7